Å·ÃÀAV

Introduction

Data from trials and practice show that ambulatory patients frequently underdose, either by: never starting dosing, omitting scheduled doses, or premature cessation of dosing. Routine methods fail to detect most of these errors. Yet variable dosing histories are a major source of variance in drug response, confounding the interpretation of all dose/time-dependent trial outcomes, eg, estimates of PK parameters, dose-dependent efficacy, regimen definition, dose-dependent toxicity. Properly analyzed dosing histories can improve learning-phase trials.

FEATURED TOPICS
•Documenting and managing adherence in clinical trials
•Methods of compiling and assessing drug dosing histories
•Adherence-informed pharmacometric analysis of effectiveness
•S²¹´Ú±ð³Ù²â
•Dosage-regimen optimization
•Regulatory issues
•L²¹²ú±ð±ô¾±²Ô²µ
•Statistical considerations.

Useful links

Venue

University of California, Washington Center

University of California, Washington Center, 1608 Rhode Island Avenue, NW, Washington, 20036, United States

Useful links

Organised by

Drug Information Association

Contact information

Marketing Manager
800 Enterprise Road, Suite 200, Horsham, 19044, United States of America
+1.215.442.6100
Contact us by email

---